CI The Cigna Group Common Stock
NYSE · Health Care · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Lug 30, 2026CI Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
CI Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
| Data ex-dividendo | Split | Tipo |
|---|---|---|
| 05 Giugno 2007 | 3-for-1 | Avanti |
| 18 Maggio 1998 | 3-for-1 | Avanti |
Informazioni su The Cigna Group Common Stock Panoramica della società da Wikipedia
The Cigna Group is an American multinational for-profit managed healthcare and insurance company based in Bloomfield, Connecticut. Cigna's insurance subsidiaries are major providers of medical, dental, disability, life and accident insurance and related products and services, the majority of which are offered through employers and other groups (e.g., governmental and non-governmental organizations, unions and associations).
Cigna is incorporated in Delaware. The company ranked No. 15 in the 2023 Fortune 500 list of the largest U.S. corporations by total revenue, and the company took 68th place in the 2023 Forbes Global 2000 ranking. It has been embroiled in controversies, including engaging in automatic denials of insurance claims without reviewing them.
History
Cigna was formed by the 1982 merger of the Connecticut General Life Insurance Company (CG) and INA Corporation (the parent corporation of Insurance Company of North America, the first stock insurance company in America). The company name, Cigna, is a mix of letters from the merging companies, CG and INA. Insurance Company of North America was formed in 1792, while CG was created in 1865 by a special act of the Governor of Connecticut. In October 1871, the great Chicago Fire burned for two days, destroyed 2,000 acres, and left 100,000 people in Illinois homeless. INA paid $650,000, one of only 51 insurance companies (out of a total of 202) to pay claims in full.
Cigna sold the majority of its life insurance operations to Lincoln National Corporation in 1997.
In October 2011, Cigna agreed to buy HealthSpring Inc. for $3.8 billion to jump-start its business selling Medicare plans from 46,000 Medicare Advantage members to almost 400,000 Medicare Advantage members. The payment would come from an issue of new equity to cover about 20 percent of the value, with the rest funded by additional cash and debt. In 2013, Cigna operated in 30 countries, had approximately 35,800 employees and managed around US$53.734 billion in assets.
In June 2015, U.S. health insurer Anthem Inc. announced that it would acquire Cigna for $47 billion in cash and stock. Anthem confirmed it had reached a deal to buy Cigna on July 24, 2015. On July 21, 2016, the US Justice Department filed an antitrust suit to block the proposed merger, and a District Court ruling on February 8, 2017, blocked the merger on anticompetitive grounds. That month, Cigna Corp. called off its $48 billion merger agreement with Anthem Inc., with Anthem stating it would "continue to enforce its rights under the merger agreement and remains committed to closing the transaction." After exhausting federal appeals of the antitrust merger block, the companies turned on each other in Delaware's Court of Chancery. The legal saga came to an end with an August 31, 2020 decision denying both companies claims for compensation from the other for the failed merger.
On March 7, 2018, it was announced that Cigna would acquire Express Scripts in a $67 billion deal and on August 24, 2018, the shareholders of Cigna and Express Scripts approved the deal.
In June 2020, Cigna formed a strategic alliance with Priority Health to make comprehensive health care coverage more affordable and accessible to Michigan employers and customers.
In September 2020, Cigna rebranded its health services portfolio under the name Evernorth, which included Express Scripts, Accredo, and eviCore.
In October 2020, it was announced that Cigna and Envision Healthcare had renewed their agreement to include Envision's clinicians as in-network providers for Cigna's members. In 2021, Molina Healthcare acquired Cigna's Medicaid contracts in Texas for US$60 million.
On February 13, 2023, Cigna renamed its holding company The Cigna Group, its health benefits provider business unit Cigna Healthcare, and its Evernorth business unit Evernorth Health Services.
In January 2024, the company agreed with the Health Care Service Corporation (HCSC) to sell Cigna Group's Medicare Advantage, Cigna Supplemental Benefits, Medicare Part D, and CareAllies businesses. The total value of the transaction is about $3.7 billion. The deal also included a four-year service agreement under which Evernorth Health Services, a subsidiary of the Cigna Group, will continue to provide pharmacy benefits to Medicare beneficiaries. The deal closed on March 19, 2025.
On 8 July 2025, HCSC announced that its newly acquired Cigna Medicare Advantage products will be renamed Healthspring, which was a dormant brand name acquired as part of HCSC deal with the Cigna Group. A logo and website for the newly revived Healthspring brand have already been launched by HCSC, which now owns Healthspring.
Cigna Global Health Benefits
Cigna Global Health Benefits is a business unit within Cigna. The company is headquartered in Wilmington, Delaware, close to Philadelphia. Additional Cigna Global Health Benefits operations are located in Visalia, California, and Greenock, Scotland and Shanghai, China and Antwerp, Belgium. Sales offices are located in North America, Europe, Asia and the Middle East.
Products and services
CGHB global health plans typically include medical, dental, behavioral, and disability coverage, as well as business travel and life insurance components. Expatriates are defined as employees of multinational companies who work outside their home country on short- or long-term international assignments. CGHB maintains its own, in-house international claims platform, and offers a network of physicians and hospitals for its members (including 550,000 in the U.S. and more than 141,000 outside the U.S.).
Public relations and lobbying
Cigna spent more than $4.4 million from 2005 to 2009 on lobbying to attain legislation that the company favors. This includes $720,000 spent in 2009 alone, when it had 20 lobbyists at five firms working on its behalf.
In 2008, the head of Cigna's public relations, Wendell Potter, resigned, becoming a whistleblower who gave testimony in 2009 to the U.S. Senate Committee on Commerce, Science and Transportation in favor of reform of the health care industry.
Controversies
Automatically rejecting claims with no review
In 2023, Cigna was criticized for allowing company doctors to reject claims even if they had not opened the patient's file. The company was found to be using a system, "PXDX," that, according to ProPublica, "saved money in two ways. It allowed Cigna to begin turning down claims that it had once paid. And it made it cheaper to turn down claims, because the company's doctors never had to open a file or conduct any in-depth review. They simply denied the claims in bulk with an electronic signature." The speed with which denials were placed was termed internally as "click and close."
Nataline Sarkisyan liver transplant case
In December 2007, Cigna refused to pay for a liver transplant of a California teenage girl, Nataline Sarkisyan, coming under scrutiny as a result. There was a liver ready and waiting to be transplanted, and doctors estimated she had a 65% chance of surviving at least six months. In response to much protest and public scrutiny, Cigna reversed its decision, though Ms. Sarkisyan died awaiting the transplant.
Even though liver transplants have been performed since 1963 and are a well-accepted treatment option for end-stage liver disease and acute liver failure, Cigna defended its actions by claiming that there was insufficient data to show that a transplant for a patient in Sarkisyan's condition would be safe and effective. The California court agreed with Cigna's position that the Sarkisyans’ claims regarding Cigna's decision-making were preempted by federal ERISA law. On April 16, 2009, the United States District Court for the Central District of California dismissed all of the claims against Cigna related to the coverage determination.
The UK newspaper The Guardian in their Esc and Ctrl videoblog about control of the Internet by corporations, documented the incident with Nataline Sarkisyan and the former vice president of Cigna talking about astroturfing, the practice of creating fake blogs by interested groups, e.g. health insurance companies, to push claims that are profitable for said company into media, e.g. dismissing universal health care.
Other controversies
In 2002, Cigna was alleged in violation of the Securities Exchange Act for earnings manipulation. Its common stock price plummeted significantly as a result.
In 2015, the American Consumer Satisfaction Index named Cigna as one of the most hated companies in the U.S. Cigna's name returned on the ACSI's most hated list in 2018.
In August 2020, the Department of Justice filed a lawsuit against Cigna alleging that the company defrauded Medicare Advantage, Medicare, and Medicaid for $1.4B by submitting diagnostic codes for health conditions that patients did not have.
In November 2020, investors sued Cigna's CEO and board, alleging that they had used "black-ops-style" tactics to "blow up" the potential merger with Anthem in 2017. One pension fund accused Cigna CEO David Cordani of seeking to poison the deal after he had failed to secure the top post in the resulting company. The fund claimed he had utilized lawyers and public relations specialists to set up a "Trojan Horse" campaign. The merger would have produced the largest U.S. health insurer in 2017.
Evaluations
Cigna received gold in the 2009 Gartner & 1to1 Customer Experience Excellence Award. The awards are given to the companies that "most clearly demonstrate exemplary customer relationship strategy and an unrivaled level of excellence in delivering the customer experience".
In January 2010, Cigna received the JD Power award for customer service for all of its call centers for the fourth time in a row.
In 2011, the California Nurses Association determined that Cigna denied roughly 39.6% of all claims (compared to competitors such as Aetna, who denied about 5.9% of all claims in the same time frame).
Strategic alliances
On April 16, 2010, Cigna announced an alliance with Humana group to offer a streamlined Medicare Advantage offering through employer clients for retirees. In November 2023, Reuters reported that Cigna and Humana were in talk to merge, in a deal totalling $60 billion. In December 2023, The Wall Street Journal reported that merger talks ended.
In November 2011, Cigna and TTK Group, an Indian business conglomerate focused on healthcare, formed a joint venture called Cigna TTK to develop a health insurance business in India, subject to obtaining government approvals.
Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | CI | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E (TTM) | 11.2media 5 anni ≈16.5 | ≈16.5 | 23.3 | Sottovalutato | |
| P/S | 0.3media 5 anni ≈0.4 | ≈0.4 | 1.3 | Sottovalutato | |
| P/B | 1.7media 5 anni ≈1.9 | ≈1.9 | 2.9 | Sottovalutato | |
| EV / EBITDA | 5.2media 5 anni ≈6.5 | ≈6.5 | 11.4 | Sottovalutato | |
| Price / Cash Flow (Prezzo / Flusso di cassa) | 7.4media 5 anni ≈8.8 | ≈8.8 | 9.8 | Sottovalutato | |
| EV / Revenue (EV / Ricavi) | 0.2media 5 anni ≈0.4 | ≈0.4 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | CI | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Margine Operativo (TTM) | 3.5%media 5 anni ≈4.2% | ≈4.2% | 8.3% | Debole | |
| Margine EBITDA (TTM) | 4.5%media 5 anni ≈5.5% | ≈5.5% | 8.8% | Debole | |
| Margine ante imposte (TTM) | 3.1%media 5 anni ≈3.3% | ≈3.3% | 3.8% | Debole | |
| Margine di Profitto Netto (TTM) | 2.2%media 5 anni ≈2.7% | ≈2.7% | 5.1% | Debole | |
| ROA (TTM) | 4.0%media 5 anni ≈3.6% | ≈3.6% | 4.0% | In linea | |
| ROE (TTM) | 15.0%media 5 anni ≈12.1% | ≈12.1% | 12.5% | In linea | |
| ROIC | 17.8%media 5 anni ≈15.9% | ≈15.9% | 9.2% | Di prim'ordine |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | CI | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto (MRQ) | 0.0media 5 anni ≈0.0 | ≈0.0 | 0.4 | Basso indebitamento | |
| Rapporto corrente (MRQ) | 0.8media 5 anni ≈0.8 | ≈0.8 | 1.4 | Bassa liquidità | |
| Quick Ratio (MRQ) | 0.7media 5 anni ≈0.6 | ≈0.6 | 0.8 | Bassa liquidità |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
| Metrica | Tendenza 5 anni | CI | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Revenue YoY (Ricavi YoY) | 11.2%media 5 anni ≈11.6% | ≈11.6% | · | · | |
| Revenue CAGR 3Y (CAGR Ricavi 3Y) | 15.0%media 5 anni ≈11.4% | ≈11.4% | · | · | |
| Revenue CAGR 5Y (CAGR Ricavi 5Y) | 11.4% | · | · | · | |
| EPS YoY | 83.0%media 5 anni ≈7.7% | ≈7.7% | · | · | |
| Net Income YoY (Utile Netto YoY) | 73.5%media 5 anni ≈1.0% | ≈1.0% | · | · | |
| EPS CAGR 3Y (CAGR EPS 3 anni) | 1.2%media 5 anni ≈-5.3% | ≈-5.3% | · | · | |
| EPS CAGR 5Y (CAGR EPS 5 anni) | -0.69% | · | · | · | |
| Net Income CAGR 3Y (CAGR Utile Netto 3 anni) | -4.2%media 5 anni ≈-11.2% | ≈-11.2% | · | · | |
| Net Income CAGR 5Y (CAGR Utile Netto 5 anni) | -6.8% | · | · | · |
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | CI | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Asset Turnover (Rotazione delle attività) | 1.8media 5 anni ≈1.4 | ≈1.4 | 1.2 | Di prim'ordine | |
| Inventory Turnover (Rotazione delle scorte) | 30.6media 5 anni ≈29.9 | ≈29.9 | 15.6 | Di prim'ordine | |
| Receivables Turnover (Rotazione dei crediti) | 10.4media 5 anni ≈11.5 | ≈11.5 | 10.5 | In linea | |
| Revenue / Employee (Ricavi / Dipendente) | ≈$4.2M | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Dividendi Rendimento, payout ratio, storico dividendi, CAGR 5Y
| Data ex-dividendo | Importo | Valuta | Rendimento |
|---|---|---|---|
| Set 8, 2026 | $1,56 | USD | ≈2.2% |
| Giu 4, 2026 | $1,56 | USD | ≈2.2% |
| Mar 5, 2026 | $1,56 | USD | ≈2.2% |
| Dic 4, 2025 | $1,51 | USD | ≈2.3% |
| Set 4, 2025 | $1,51 | USD | ≈2.0% |
| Giu 3, 2025 | $1,51 | USD | ≈1.9% |
| Mar 5, 2025 | $1,51 | USD | ≈1.8% |
| Dic 4, 2024 | $1,40 | USD | ≈1.7% |
| Set 4, 2024 | $1,40 | USD | ≈1.5% |
| Giu 4, 2024 | $1,40 | USD | ≈1.6% |
| Mar 5, 2024 | $1,40 | USD | ≈1.5% |
| Dic 5, 2023 | $1,23 | USD | ≈1.9% |
| Set 5, 2023 | $1,23 | USD | ≈1.7% |
| Giu 6, 2023 | $1,23 | USD | ≈1.8% |
| Mar 7, 2023 | $1,23 | USD | ≈1.6% |
| Dic 5, 2022 | $1,12 | USD | ≈1.4% |
| Set 6, 2022 | $1,12 | USD | ≈1.5% |
| Giu 7, 2022 | $1,12 | USD | ≈1.6% |
| Mar 8, 2022 | $1,12 | USD | ≈1.8% |
| Dic 6, 2021 | $1,00 | USD | ≈1.9% |
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Lug 29, 2026 | $7.78 | $7.83 | -0.59% |
| 31 Marzo 2026 | $7.79 | $7.84 | -0.65% | |
| 31 Dicembre 2025 | $8.08 | $8.11 | -0.41% | |
| 30 Settembre 2025 | $7.83 | $7.88 | -0.60% | |
| 30 Giugno 2025 | $7.20 | $7.37 | -2.3% | |
| 31 Marzo 2025 | $6.74 | $6.54 | 3.0% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $274.90B | $247.12B | $195.26B | $180.52B | $174.07B | $160.40B | $153.57B | $48.65B | $41.81B | $39.84B | |
| Cost of Revenue | $214.99B | $182.51B | $133.80B | $124.83B | $117.55B | $103.48B | $97.67B | $4.79B | $2.46B | $2.47B | |
| SG&A Expense | $14.62B | $14.84B | $14.82B | $13.17B | $13.01B | $14.07B | $14.05B | $11.93B | $10.03B | $9.79B | |
| Operating Income | $9.20B | $9.42B | $8.54B | $8.45B | $7.94B | $8.15B | $8.08B | $4.16B | $3.94B | $3.09B | |
| Other Non-op | $-1.41B | $-1.44B | $-1.45B | $-1.23B | $-1.21B | $-1.44B | $-1.68B | $-498M | $-252M | $-278M | |
| Pretax Income | $7.78B | $5.27B | $5.51B | $8.40B | $6.79B | $10.87B | $6.57B | $3.58B | $3.61B | $2.98B | |
| Income Tax | $1.49B | $1.49B | $141M | $1.61B | $1.37B | $2.38B | $1.45B | $935M | $1.37B | $1.14B | |
| Net Income | $5.96B | $3.43B | $5.16B | $6.78B | $5.42B | $8.49B | $5.12B | $2.65B | $2.23B | $1.84B | |
| EPS (Basic) | $22.33 | $12.25 | $17.57 | $21.66 | $15.89 | $23.17 | $13.58 | $10.69 | $8.92 | $7.31 | |
| EPS (Diluted) | $22.18 | $12.12 | $17.39 | $21.41 | $15.75 | $22.96 | $13.44 | $10.54 | $8.77 | $7.19 | |
| Shares (Diluted) | 268,563,000 | 283,218,000 | 296,882,000 | 313,065,000 | 340,966,000 | 368,389,000 | 379,817,000 | 250,225,000 | 255,072,000 | 259,647,000 | |
| EBITDA | $11.97B | $12.19B | $11.57B | $11.35B | $10.86B | $10.96B | $11.73B | $4.86B | · | · |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7.68B | $7.55B | $7.82B | $5.92B | $5.08B | $10.18B | $4.62B | $3.85B | $2.97B | $3.19B | |
| Short-term Investments | $1.06B | $665M | $925M | $905M | $920M | $1.33B | $937M | $2.04B | $2.14B | · | |
| Receivables | $28.77B | $24.23B | $17.72B | $17.22B | $15.07B | $12.19B | $10.72B | $10.47B | $3.15B | · | |
| Inventory | $7.34B | $6.69B | $5.64B | $4.78B | $3.72B | $3.17B | $2.66B | $2.82B | $228M | · | |
| Other Current Assets | $2.98B | $2.73B | $2.17B | $1.30B | $1.28B | $930M | $1.40B | $1.24B | $820M | · | |
| Current Assets | $47.81B | $48.87B | $37.35B | $30.12B | $36.13B | $27.80B | $29.84B | $20.43B | $9.31B | · | |
| PP&E (Net) | $3.65B | · | · | $3.77B | $3.69B | $4.21B | $4.42B | $4.56B | $1.56B | · | |
| PP&E (Gross) | $13.75B | · | · | $11.20B | $10.28B | $9.78B | $8.92B | $7.96B | $4.61B | · | |
| Accum. Depreciation | $10.10B | · | · | $7.43B | $6.59B | $5.58B | $4.50B | $3.40B | $3.05B | · | |
| Goodwill | $44.92B | $44.37B | $44.26B | $45.81B | $45.81B | $44.65B | $44.60B | $44.51B | $6.16B | $5.98B | |
| Intangibles | $28.56B | $29.42B | $30.86B | $32.49B | $34.10B | $35.18B | $36.56B | $39.00B | $345M | · | |
| Other Non-current Assets | $2.88B | $2.79B | $3.42B | $2.70B | $3.40B | $2.69B | $2.28B | $1.63B | $1.43B | · | |
| Total Assets | $157.92B | $155.88B | $152.76B | $143.88B | $154.89B | $155.45B | $155.77B | $153.23B | $61.76B | · | |
| Accounts Payable | $10.66B | $9.29B | $8.55B | $7.78B | $6.66B | $5.48B | $5.09B | $4.37B | $184M | · | |
| Short-term Debt | $0 | $880M | $1.24B | $0 | $2.03B | $1.03B | $944M | $1.50B | $100M | · | |
| Current Liabilities | $56.34B | $57.98B | $48.72B | $41.23B | $43.57B | $36.02B | $40.14B | $31.89B | $11.01B | · | |
| Capital Leases | · | · | $340M | $346M | · | $491M | $465M | · | · | · | |
| Deferred Tax | $7.14B | $6.97B | $7.17B | $7.79B | $8.35B | $8.94B | $9.39B | $9.45B | $0 | · | |
| Other Non-current Liabilities | $4.24B | $3.21B | $3.44B | $2.77B | $3.76B | $4.63B | $4.46B | $3.47B | $2.84B | · | |
| Total Liabilities | $116.05B | $114.64B | $106.41B | $99.13B | $107.70B | $105.06B | $110.39B | $112.15B | $48.00B | · | |
| Long-term Debt | · | · | · | · | · | · | · | $39.52B | · | · | |
| Total Debt | $0 | $880M | $1.24B | $0 | $2.03B | $1.03B | $944M | $1.50B | · | · | |
| Common Stock | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $74M | · | |
| Retained Earnings | $47.87B | $43.52B | $41.65B | $37.94B | $32.59B | $28.57B | $20.16B | $15.09B | $15.80B | · | |
| Treasury Stock | $35.14B | $31.44B | $24.24B | $21.84B | $14.18B | $6.37B | $2.19B | $104M | $4.02B | · | |
| AOCI | $-2.81B | $-2.34B | $-1.86B | $-1.66B | $-884M | $-861M | $-941M | $-1.71B | $-1.08B | · | |
| Stockholders' Equity | $41.71B | $41.03B | $46.22B | $44.67B | $47.11B | $50.32B | $45.34B | $41.03B | $13.71B | · | |
| Liabilities + Equity | $157.92B | $155.88B | $152.76B | $143.88B | $154.89B | $155.45B | $155.77B | $153.23B | $61.76B | · | |
| Shares Outstanding | 263,464,000 | 273,789,000 | 292,504,000 | 298,676,000 | 322,948,000 | 354,771,000 | 372,531,000 | 380,924,000 | 0 | 0 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2.77B | $2.77B | $3.04B | $2.94B | $2.92B | $2.80B | $3.65B | $695M | $566M | $610M | |
| Deferred Tax | $326M | $-95M | $-1.66B | $-472M | $-216M | $-386M | $-313M | $-101M | $242M | $74M | |
| Amort. of Intangibles | $1.74B | $1.70B | $1.82B | $1.88B | $2.00B | $1.98B | $2.95B | $235M | $115M | $151M | |
| Restructuring | · | $0 | $252M | $22M | $168M | · | · | · | · | · | |
| Other Non-cash | $543M | $3.90B | $5.07B | $-547M | $-927M | $-555M | $1.03B | $530M | · | · | |
| Operating Cash Flow | $9.60B | $10.36B | $11.81B | $8.66B | $7.19B | $10.35B | $9.48B | $3.77B | $4.09B | $4.03B | |
| CapEx | · | · | · | · | · | · | $1.05B | $528M | $471M | $461M | |
| Investing Cash Flow | $-4.41B | $-2.10B | $-5.17B | $3.10B | $-3.61B | $2.98B | $-734M | $-26.38B | $-1.70B | $-2.57B | |
| Debt Issued | $4.46B | $4.46B | $1.49B | $0 | $4.26B | $3.46B | $0 | $22.86B | $1.58B | $0 | |
| Net Debt Issued | $261M | $1.46B | $-1.48B | $-500M | $-318M | $-4.58B | $-4.49B | $22.73B | · | · | |
| Stock Issued | $203M | $305M | $187M | $389M | $326M | $376M | $224M | $68M | $131M | $36M | |
| Stock Repurchased | $3.62B | $7.03B | $2.28B | $7.61B | $7.74B | $4.04B | $1.99B | $342M | $2.73B | $139M | |
| Net Stock Activity | $-3.42B | $-6.73B | $-2.10B | $-7.22B | $-7.42B | $-3.67B | $-1.76B | $-274M | · | · | |
| Dividends Paid | $1.61B | $1.57B | $1.45B | $1.38B | $1.34B | $15M | $15M | · | · | · | |
| Financing Cash Flow | $-6.42B | $-7.65B | $-4.29B | $-11.24B | $-8.21B | $-8.53B | $-7.19B | $23.52B | $-2.65B | $-225M | |
| Net Change in Cash | $-1.20B | $594M | $2.36B | $428M | $-4.70B | $4.83B | $1.56B | $883M | $-213M | $1.22B | |
| Taxes Paid | $399M | $898M | $1.47B | $1.85B | $2.24B | $1.84B | $1.78B | $1.02B | $1.04B | $1.06B | |
| Free Cash Flow | · | · | · | · | · | · | $8.44B | $3.24B | · | · |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.4% | 3.8% | 4.4% | 4.7% | 4.6% | 5.1% | 5.3% | 8.6% | · | · | |
| Net Margin | 2.2% | 1.5% | 2.8% | 3.7% | 3.1% | 5.3% | 3.3% | 5.4% | · | · | |
| Pretax Margin | 2.8% | 2.1% | 2.8% | 4.6% | 3.9% | 6.8% | 4.3% | 7.4% | · | · | |
| EBITDA Margin | 4.4% | 4.9% | 5.9% | 6.3% | 6.2% | 6.8% | 7.6% | 10.0% | · | · | |
| ROA | 3.8% | 2.5% | 3.6% | 4.5% | 3.5% | 5.5% | 3.3% | 2.5% | · | · | |
| ROE | 14.4% | 8.7% | 11.8% | 14.7% | 11.1% | 17.8% | 11.9% | 9.7% | · | · | |
| ROIC | 17.8% | 16.1% | 17.5% | 15.1% | 12.9% | 12.4% | 13.6% | 7.2% | · | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.8 | 0.8 | 0.7 | 0.8 | 0.8 | 0.7 | 0.6 | · | · | |
| Quick Ratio | 0.7 | 0.6 | 0.5 | 0.6 | 0.5 | 0.7 | 0.4 | 0.5 | · | · | |
| Debt / Equity | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | · |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.8 | 1.6 | 1.3 | 1.2 | 1.1 | 1.0 | 1.0 | 0.5 | · | · | |
| Inventory Turnover | 30.6 | 29.6 | 25.7 | 29.4 | 34.1 | 35.5 | 35.6 | 3.1 | · | · | |
| Receivables Turnover | 10.4 | 11.8 | 11.2 | 11.2 | 12.8 | 14.0 | 14.5 | 7.1 | · | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $158.33 | $149.87 | $158.03 | $150.24 | $145.88 | $141.84 | $121.70 | $107.71 | · | · | |
| Revenue / Share | $1023.60 | $872.55 | $657.72 | $576.61 | $510.54 | $435.41 | $404.32 | $194.43 | · | · | |
| Cash Flow / Share | $35.75 | $36.59 | $39.79 | $27.65 | $21.09 | $28.10 | $24.97 | $15.07 | · | · | |
| Cash / Share | $29.13 | $27.58 | $26.74 | $19.83 | $15.73 | $28.70 | $12.40 | $10.12 | · | · | |
| Dividend / Share | $6.04 | $5.60 | $4.92 | $4.48 | $4.00 | $0.04 | $0.04 | $0.04 | $0.04 | · | |
| EPS (TTM) | $22.18 | $12.12 | $17.39 | $21.41 | $15.75 | $22.96 | $13.44 | $10.54 | · | · |
Tassi di Crescita
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.2% | 26.6% | 8.2% | 3.7% | 8.5% | · | · | · | · | · | |
| Revenue CAGR 3Y | 15.0% | 12.4% | 6.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.4% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 83.0% | -30.3% | -18.8% | 35.9% | -31.4% | · | · | · | · | · | |
| EPS CAGR 3Y | 1.2% | -8.4% | -8.8% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -0.69% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 73.5% | -33.5% | -23.9% | 25.1% | -36.1% | · | · | · | · | · | |
| Net Income CAGR 3Y | -4.2% | -14.1% | -15.3% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -6.8% | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 154.8% | · | · | · | · | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $274.90B | $247.12B | $195.26B | $180.52B | $174.07B | $160.40B | $153.57B | $48.65B | · | · | |
| Net Income TTM | $5.96B | $3.43B | $5.16B | $6.78B | $5.42B | $8.49B | $5.12B | $2.65B | · | · | |
| Market Cap | $72.51B | $75.60B | $87.59B | $98.96B | $74.16B | $73.86B | $76.18B | $72.35B | · | · | |
| Enterprise Value | $63.78B | $68.27B | $80.08B | $92.13B | $70.18B | $63.37B | $71.57B | $67.95B | · | · | |
| P/E | 12.4 | 22.8 | 17.2 | 15.5 | 14.6 | 9.1 | 15.2 | 18.0 | · | · | |
| P/S | 0.3 | 0.3 | 0.4 | 0.5 | 0.4 | 0.5 | 0.5 | 1.5 | · | · | |
| P/B | 1.7 | 1.8 | 1.9 | 2.2 | 1.6 | 1.5 | 1.7 | 1.8 | · | · | |
| P / Cash Flow | 7.6 | 7.3 | 7.4 | 11.4 | 10.3 | 7.1 | 8.0 | 19.2 | · | · | |
| P / FCF | · | · | · | · | · | · | 9.0 | 22.3 | · | · | |
| EV / EBITDA | 5.3 | 5.6 | 6.9 | 8.1 | 6.5 | 5.8 | 6.1 | 14.0 | · | · | |
| EV / FCF | · | · | · | · | · | · | 8.5 | 21.0 | · | · | |
| EV / Revenue | 0.2 | 0.3 | 0.4 | 0.5 | 0.4 | 0.4 | 0.5 | 1.4 | · | · | |
| Dividend Yield | 2.2% | 2.1% | 1.7% | 1.4% | 1.8% | 0.02% | 0.02% | · | · | · | |
| Earnings Yield | 8.1% | 4.4% | 5.8% | 6.5% | 6.9% | 11.0% | 6.6% | 5.5% | · | · | |
| Payout Ratio | 27.0% | 41.5% | 27.0% | 20.5% | 24.8% | · | · | · | · | · | |
| Annual Payout | $1.61B | $1.57B | $1.45B | $1.38B | $1.34B | $15M | $15M | · | · | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $71.67B | $68.49B | $72.47B | $69.75B | $67.18B | $65.50B | $65.65B | $63.69B | $60.52B | $57.26B | $51.11B | $49.05B | $48.59B | $46.52B | $45.75B | $45.28B | |
| Cost of Revenue | $56.70B | $54.10B | $57.80B | $55.53B | $53.27B | $48.40B | $49.02B | $47.56B | $44.49B | $41.43B | $35.26B | $33.64B | $33.44B | $31.46B | $32.09B | $31.78B | |
| SG&A Expense | $3.47B | $3.72B | $3.61B | $3.36B | $3.43B | $4.21B | $3.87B | $3.59B | $3.68B | $3.71B | $4.06B | $3.79B | $3.43B | $3.54B | $3.48B | $3.15B | |
| Operating Income | $2.68B | $2.36B | $2.35B | $2.58B | $2.31B | $1.97B | $2.17B | $2.58B | $2.41B | $2.26B | $2.06B | $2.24B | $2.22B | $2.02B | $1.75B | $2.14B | |
| Other Non-op | $-356M | $-357M | $-362M | $-347M | $-337M | $-362M | $-362M | $-376M | $-375M | $-322M | $-360M | $-365M | $-363M | $-358M | $-324M | $-304M | |
| Pretax Income | $2.26B | $2.27B | $1.82B | $2.29B | $2.02B | $1.65B | $2.01B | $1.19B | $1.99B | $79M | $188M | $1.84B | $1.88B | $1.60B | $1.36B | $3.49B | |
| Income Tax | $382M | $409M | $543M | $322M | $389M | $239M | $473M | $367M | $360M | $291M | $-919M | $391M | $374M | $295M | $136M | $713M | |
| Net Income | $1.66B | $1.65B | $943M | $1.97B | $1.53B | $1.32B | $1.19B | $825M | $1.63B | $-212M | $899M | $1.45B | $1.51B | $1.31B | $1.22B | $2.78B | |
| EPS (Basic) | $6.31 | $6.30 | $4.67 | $7.02 | $5.76 | $4.88 | $5.06 | $2.65 | $5.51 | $-0.97 | $3.54 | $4.79 | $4.96 | $4.28 | $3.89 | $9.07 | |
| EPS (Diluted) | $6.29 | $6.26 | $4.64 | $6.98 | $5.71 | $4.85 | $5.01 | $2.63 | $5.45 | $-0.97 | $3.49 | $4.74 | $4.92 | $4.24 | $3.82 | $8.97 | |
| Shares (Diluted) | 263,962,000 | 264,017,000 | · | 267,530,000 | 268,154,000 | 272,953,000 | · | 281,396,000 | 284,052,000 | 286,465,000 | · | 297,131,000 | 296,879,000 | 298,999,000 | · | 307,517,000 | |
| EBITDA | $3.33B | $3.01B | · | $3.27B | $2.99B | $2.65B | · | $2.58B | $2.41B | $3.00B | · | $2.24B | $2.22B | $2.76B | · | $2.14B |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6.30B | $7.04B | $7.68B | $6.03B | $4.33B | $8.33B | $7.55B | $5.89B | $6.79B | $8.44B | · | $8.50B | $9.59B | $7.93B | · | $7.08B | |
| Short-term Investments | $959M | $812M | $1.06B | $883M | $813M | $727M | $665M | $864M | $1.07B | $1.11B | · | $1.05B | $872M | $914M | · | $783M | |
| Receivables | $30.80B | $26.61B | $28.77B | $31.71B | $31.15B | $26.93B | $24.23B | $27.85B | $25.11B | $20.56B | · | $19.08B | $18.33B | $17.70B | · | $17.27B | |
| Inventory | $5.85B | $5.83B | $7.34B | $5.63B | $5.97B | $5.18B | $6.69B | $5.08B | $5.17B | $4.63B | · | $4.42B | $4.51B | $4.21B | · | $4.02B | |
| Other Current Assets | $3.09B | $2.74B | $2.98B | $2.49B | $2.47B | $2.39B | $2.73B | $2.67B | $2.66B | $2.26B | · | $1.48B | $1.41B | $1.26B | · | $1.02B | |
| Current Assets | $46.99B | $43.03B | $47.81B | $46.73B | $44.72B | $43.55B | $48.87B | $49.22B | $46.22B | $43.36B | · | $34.52B | $34.71B | $32.03B | · | $30.17B | |
| PP&E (Net) | · | · | $3.65B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| PP&E (Gross) | · | · | $13.75B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $10.10B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Goodwill | $45.53B | $45.53B | $44.92B | $44.92B | $44.38B | $44.37B | $44.37B | $44.37B | $44.26B | $44.26B | $44.26B | $45.81B | $45.81B | $45.81B | $45.81B | $45.81B | |
| Intangibles | $26.93B | $27.32B | $28.56B | $28.98B | $28.67B | $29.05B | $29.42B | $29.79B | $30.18B | $30.49B | · | $31.32B | $31.71B | $32.10B | · | $32.88B | |
| Other Non-current Assets | $3.32B | $3.25B | $2.88B | $3.39B | $2.93B | $3.00B | $2.79B | $3.18B | $3.28B | $3.29B | · | $3.15B | $2.50B | $2.56B | · | $2.48B | |
| Total Assets | $157.08B | $153.27B | $157.92B | $157.92B | $151.65B | $150.66B | $155.88B | $157.64B | $155.45B | $153.12B | · | $149.65B | $150.05B | $147.98B | · | $144.21B | |
| Accounts Payable | $10.41B | $9.88B | $10.66B | $9.35B | $9.94B | $9.14B | $9.29B | $8.52B | $9.28B | $8.12B | · | $7.67B | $8.07B | $7.36B | · | $6.87B | |
| Short-term Debt | $1.00B | · | $0 | · | · | $0 | $880M | $1.64B | $790M | $884M | · | $1.51B | $200M | · | · | $0 | |
| Current Liabilities | $55.56B | $52.61B | $56.34B | $56.45B | $56.78B | $55.74B | $57.98B | $57.06B | $55.37B | $51.98B | · | $47.06B | $47.34B | $44.73B | · | $41.12B | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $368M | |
| Deferred Tax | $6.73B | $6.85B | $7.14B | $7.00B | $6.78B | $6.88B | $6.97B | $6.79B | $6.95B | $7.03B | · | $7.48B | $7.59B | $7.71B | · | $7.78B | |
| Other Non-current Liabilities | $5.61B | $4.77B | $4.24B | $3.87B | $3.65B | $3.58B | $3.21B | $3.03B | $3.54B | $3.65B | · | $2.93B | $2.58B | $2.69B | · | $3.18B | |
| Total Liabilities | $114.17B | $110.82B | $116.05B | $115.91B | $111.22B | $110.24B | $114.64B | $115.34B | $113.92B | $111.77B | · | $103.88B | $104.53B | $103.38B | · | $99.08B | |
| Total Debt | $1.00B | · | · | · | · | $0 | · | $1.64B | $790M | $884M | · | $1.51B | $200M | · | · | $0 | |
| Common Stock | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | · | $4M | $4M | $4M | · | $4M | |
| Retained Earnings | $50.35B | $49.11B | $47.87B | $47.03B | $45.56B | $44.43B | $43.52B | $42.48B | $42.13B | $40.98B | · | $40.98B | $39.94B | $38.84B | · | $37.04B | |
| Treasury Stock | $35.47B | $35.22B | $35.14B | $34.13B | $34.13B | $33.06B | $31.44B | $29.41B | $29.41B | $27.77B | · | $23.74B | $23.05B | $22.91B | · | $19.39B | |
| AOCI | $-4.36B | $-3.60B | $-2.81B | $-2.80B | $-2.82B | $-2.59B | $-2.34B | $-2.16B | $-2.44B | $-2.32B | · | $-2.12B | $-1.88B | $-1.77B | · | $-2.01B | |
| Stockholders' Equity | $42.62B | $42.21B | $41.71B | $41.80B | $40.21B | $40.23B | $41.03B | $42.09B | $41.33B | $41.18B | · | $45.69B | $45.45B | $44.50B | · | $45.04B | |
| Liabilities + Equity | $157.08B | $153.27B | $157.92B | $157.92B | $151.65B | $150.66B | $155.88B | $157.64B | $155.45B | $153.12B | · | $149.65B | $150.05B | $147.98B | · | $144.21B | |
| Shares Outstanding | · | · | 263,464,000 | · | · | · | 273,789,000 | · | · | · | 292,504,000 | · | · | · | 298,676,000 | · |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $655M | $650M | $722M | $697M | $682M | $674M | $646M | $650M | $738M | $741M | $765M | $766M | $755M | $749M | $735M | $726M | |
| Amort. of Intangibles | $389M | $390M | $463M | $436M | $422M | $422M | $424M | $436M | $420M | $423M | $451M | $454M | $455M | $459M | $457M | $460M | |
| Restructuring | · | · | · | $222M | $129M | $215M | · | $0 | $0 | $0 | $252M | $0 | $0 | · | $0 | $0 | |
| Other Non-cash | · | $-1.17B | · | · | · | $-163M | · | · | · | $4.31B | · | · | · | $2.97B | · | · | |
| Operating Cash Flow | $-421M | $1.13B | $6.15B | $3.42B | $-1.89B | $1.92B | $5.21B | $46M | $265M | $4.84B | $1.47B | $2.83B | $2.49B | $5.03B | $2.10B | $3.28B | |
| Investing Cash Flow | $-503M | $-637M | $-420M | $-4.39B | $-797M | $1.20B | $-191M | $-776M | $-640M | $-495M | $-440M | $-1.34B | $-414M | $-2.98B | $-616M | $4.45B | |
| Debt Issued | · | · | $-3M | $4.46B | $0 | $0 | $0 | $0 | $0 | $4.46B | $0 | $0 | $0 | $1.49B | $0 | $0 | |
| Net Debt Issued | · | $-550M | · | · | · | $-700M | · | · | · | $2.25B | · | · | · | $1.41B | · | · | |
| Stock Issued | $101M | $57M | $25M | $37M | $72M | $69M | $22M | $62M | $40M | $181M | $74M | $54M | $29M | $30M | $72M | $100M | |
| Stock Repurchased | $280M | $0 | $1.00B | $0 | $1.11B | $1.51B | $2.02B | $0 | $990M | $4.02B | $544M | $624M | $154M | $962M | $1.73B | $3.50B | |
| Net Stock Activity | · | $57M | · | · | · | $-1.44B | · | · | · | $-3.84B | · | · | · | $-932M | · | · | |
| Dividends Paid | $409M | $417M | $396M | $402M | $401M | $412M | $384M | $390M | $392M | $401M | $358M | $362M | $362M | $368M | $334M | $341M | |
| Financing Cash Flow | $207M | $-1.14B | $-4.07B | $2.66B | $-1.33B | $-3.68B | $-3.25B | $439M | $-2.31B | $-2.53B | $-1.25B | $-2.57B | $-435M | $-37M | $-2.64B | $-5.52B | |
| Net Change in Cash | $-724M | $-656M | $1.67B | $1.69B | $-3.99B | $-555M | $1.75B | $-273M | $-2.69B | $1.81B | $-209M | $-1.09B | $1.65B | $2.01B | $-1.14B | $2.19B | |
| Taxes Paid | · | · | $43M | $6M | $210M | $140M | $59M | $272M | $457M | $110M | $91M | $454M | $849M | $77M | $504M | $435M |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.7% | 3.4% | · | 3.7% | 3.4% | 3.0% | · | 4.0% | 4.0% | 3.9% | · | 4.6% | 4.6% | 4.3% | · | 4.7% | |
| Net Margin | 2.3% | 2.4% | · | 2.8% | 2.4% | 2.1% | · | 1.3% | 2.7% | -0.37% | · | 2.9% | 3.1% | 2.8% | · | 6.1% | |
| Pretax Margin | 3.1% | 3.3% | · | 3.3% | 3.0% | 2.5% | · | 1.9% | 3.3% | 0.14% | · | 3.8% | 3.9% | 3.4% | · | 7.7% | |
| EBITDA Margin | 4.7% | 4.4% | · | 4.7% | 4.5% | 4.0% | · | 4.0% | 4.0% | 5.2% | · | 4.6% | 4.6% | 5.9% | · | 4.7% | |
| ROA | 1.1% | 1.1% | · | 1.2% | 1.1% | 0.93% | · | 0.54% | 1.1% | -0.14% | · | 0.99% | 1.0% | 0.87% | · | 1.9% | |
| ROE | 4.0% | 4.0% | · | 4.7% | 4.0% | 3.5% | · | 1.9% | 3.8% | -0.49% | · | 3.2% | 3.3% | 2.9% | · | 6.0% | |
| ROIC | 5.1% | 4.6% | · | 5.3% | 4.6% | 4.2% | · | 4.1% | 4.7% | -14.4% | · | 3.7% | 3.9% | 3.7% | · | 3.8% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.9 | 0.8 | 0.8 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | |
| Quick Ratio | 0.7 | 0.7 | · | 0.7 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | |
| Debt / Equity | 0.0 | · | · | · | · | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | 0.0 |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Inventory Turnover | 9.6 | 9.8 | · | 10.4 | 9.6 | 9.9 | · | 10.0 | 9.2 | 9.4 | · | 8.0 | 8.1 | 8.2 | · | 9.0 | |
| Receivables Turnover | 2.3 | 2.6 | · | 2.3 | 2.4 | 2.8 | · | 2.7 | 2.8 | 3.0 | · | 2.7 | 2.7 | 2.8 | · | 2.7 |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $271.51 | $259.43 | · | $260.71 | $250.52 | $239.98 | · | $226.35 | $213.07 | $199.87 | · | $165.07 | $163.66 | $155.58 | · | $147.24 | |
| Cash Flow / Share | · | $4.28 | · | · | · | $7.03 | · | · | · | $16.90 | · | · | · | $16.82 | · | · | |
| Dividend / Share | $1.56 | $1.56 | $1.51 | $1.51 | $1.51 | $1.51 | $1.40 | $1.40 | $1.40 | $1.40 | $1.23 | $1.23 | $1.23 | $1.23 | $1.12 | $1.12 | |
| EPS (TTM) | $24.17 | $23.59 | · | $22.55 | $18.20 | $17.94 | · | $10.60 | $12.71 | $12.18 | · | $17.72 | $21.95 | $21.92 | · | $20.99 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $282.38B | $277.89B | · | $268.08B | $262.02B | $255.37B | · | $232.59B | $217.94B | $206.00B | · | $189.90B | $186.14B | $183.03B | · | $180.44B | |
| Net Income TTM | $6.23B | $6.10B | · | $6.02B | $4.87B | $4.97B | · | $3.14B | $3.77B | $3.65B | · | $5.49B | $6.82B | $6.88B | · | $6.70B | |
| P/E | 11.4 | 11.3 | · | 12.8 | 18.2 | 18.3 | · | 32.7 | 26.0 | 29.8 | · | 16.1 | 12.8 | 11.7 | · | 13.2 | |
| Earnings Yield | 8.8% | 8.8% | · | 7.8% | 5.5% | 5.5% | · | 3.1% | 3.8% | 3.4% | · | 6.2% | 7.8% | 8.6% | · | 7.6% | |
| Payout Ratio | · | 25.2% | · | · | · | 29.2% | · | · | · | -189.2% | · | · | · | 28.2% | · | · | |
| Annual Payout | $1.62B | $1.62B | · | $1.60B | $1.59B | $1.58B | · | $1.54B | $1.51B | $1.48B | · | $1.43B | $1.41B | $1.40B | · | $1.37B |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ricavi | $274.90B | $247.12B | $195.26B | $180.52B | $174.07B |
| Margine Operativo % | 3.4% | 3.8% | 4.4% | 4.7% | 4.6% |
| Utile netto | $5.96B | $3.43B | $5.16B | $6.78B | $5.42B |
| EPS Diluito | $22.18 | $12.12 | $17.39 | $21.41 | $15.75 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Rapporto corrente | 0.8 | 0.8 | 0.8 | 0.7 | 0.8 |
| Quick Ratio | 0.7 | 0.6 | 0.5 | 0.6 | 0.5 |
Dati fondamentali insufficienti per creare questo bilancio al momento.
Proprietari istituzionali (13F) 1.867 filer · $73.0B totale · Aggiornato al 30 Settembre 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 160 (-31 vs trimestre precedente) | 92 (-24 vs trimestre precedente) | 684 (+29 vs trimestre precedente) | 593 (+10 vs trimestre precedente) | +5.4M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $7.203.753.597 | 26.173.577 | 9,87% | Azioni |
| BlackRock, Inc. | $6.461.456.854 | 23.438.250 | 8,85% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $4.762.729.281 | 17.276.296 | 6,53% | Azioni |
| STATE STREET CORP | $3.496.245.161 | 12.682.259 | 4,79% | Azioni |
| Dodge & Cox | $3.356.093.871 | 12.173.875 | 4,60% | Azioni |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $2.895.610.431 | 10.443.691 | 3,97% | Azioni |
| Sanders Capital, LLC | $2.796.668.015 | 10.144.617 | 3,83% | Azioni |
| FMR LLC | $2.210.454.198 | 8.018.189 | 3,03% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $1.720.317.832 | 6.268.347 | 2,36% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.717.104.307 | 6.228.614 | 2,35% | Azioni |
| GQG Partners LLC | $1.628.918.123 | 5.908.707 | 2,23% | Azioni |
| JPMORGAN CHASE & CO | $1.447.877.312 | 5.194.363 | 1,98% | Azioni |
| MORGAN STANLEY | $1.017.483.597 | 3.690.812 | 1,39% | Azioni |
| NORGES BANK | $982.164.860 | 3.562.699 | 1,35% | Azioni |
| BANK OF AMERICA CORP /DE/ | $827.692.197 | 3.002.366 | 1,13% | Azioni |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $785.495.575 | 2.849.302 | 1,08% | Azioni |
| NORTHERN TRUST CORP | $752.795.794 | 2.730.687 | 1,03% | Azioni |
| AMERIPRISE FINANCIAL INC | $719.183.166 | 2.608.447 | 0,99% | Azioni |
| Grantham, Mayo, Van Otterloo & Co. LLC | $710.448.797 | 2.577.075 | 0,97% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $692.582.460 | 2.512.025 | 0,95% | Azioni |
| Invesco Ltd. | $662.627.873 | 2.403.612 | 0,91% | Azioni |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $656.057.221 | 2.459.446 | 0,90% | Azioni |
| Davis Selected Advisers | $621.243.564 | 2.253.424 | 0,85% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $600.668.400 | 2.178.861 | 0,82% | Azioni |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $558.018.223 | 2.024.152 | 0,76% | Azioni |
| Boston Partners | $555.607.176 | 2.014.660 | 0,76% | Azioni |
| GOLDMAN SACHS GROUP INC | $548.715.710 | 1.990.408 | 0,75% | Azioni |
| Legal & General Group Plc | $542.779.462 | 1.968.875 | 0,74% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $499.838.165 | 1.813.110 | 0,68% | Azioni |
| Amundi | $472.966.222 | 1.715.636 | 0,65% | Azioni |
| Bank of New York Mellon Corp | $450.936.717 | 1.635.725 | 0,62% | Azioni |
| NORDEA INVESTMENT MANAGEMENT AB | $409.669.412 | 1.476.499 | 0,56% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $409.373.497 | 1.484.959 | 0,56% | Azioni |
| AQR CAPITAL MANAGEMENT LLC | $396.029.634 | 1.436.556 | 0,54% | Azioni |
| NATIONAL BANK OF CANADA /FI/ | $396.005.041 | 1.436.453 | 0,54% | Azioni |
| Nuveen, LLC | $372.070.579 | 1.349.647 | 0,51% | Azioni |
| Capital World Investors | $365.436.721 | 1.325.583 | 0,50% | Azioni |
| DEUTSCHE BANK AG\ | $352.569.909 | 1.278.910 | 0,48% | Azioni |
| Capital Research Global Investors | $340.312.625 | 1.234.448 | 0,47% | Azioni |
| VICTORY CAPITAL MANAGEMENT INC | $297.765.000 | 1.080.111 | 0,41% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $295.639.232 | 1.072.400 | 0,41% | Opzione Call |
| RAYMOND JAMES FINANCIAL INC | $285.021.252 | 1.033.884 | 0,39% | Azioni |
| BloombergSen Inc. | $250.400.144 | 908.300 | 0,34% | Opzione Call |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $241.311.801 | 875.333 | 0,33% | Azioni |
| Russell Investments Group, Ltd. | $233.022.643 | 844.481 | 0,32% | Azioni |
| BRANDES INVESTMENT PARTNERS, LP | $232.489.133 | 843.317 | 0,32% | Azioni |
| National Pension Service | $218.948.088 | 794.211 | 0,30% | Azioni |
| UBS Group AG | $213.774.402 | 775.444 | 0,29% | Azioni |
| Sumitomo Mitsui Trust Group, Inc. | $210.159.410 | 762.331 | 0,29% | Azioni |
| Swiss National Bank | $205.012.464 | 743.661 | 0,28% | Azioni |
Insider aziendali 41 insider · 8 dirigenti · 11 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Everett Neville | EVP, Special Advisor to the CEO | 03 Settembre 2026 S | 5.053 | 0 | 2 | $-671.895 |
| Brian C Evanko | President and Chief Executive Officer | 01 Settembre 2026 A | 41.030 | 0 | 1 | $-1.610.400 |
| David Cordani | Chairman & CEO | 13 Maggio 2026 M | 57.766 | 1 | 13 | $-58.114.037 |
| Ann M Dennison | EVP, CFO | 27 Febbraio 2026 A | 7.745 | 0 | 0 | $0 |
| Nicole S Jones | EVP, Chief Administrative Officer and Chief Human Resources Officer | 18 Agosto 2026 S | 25.880 | 0 | 3 | $-6.784.615 |
| Bryan Holgerson | Title - President, Cigna Healthcare U.S. and EVP, Customer Health Outcomes | 06 Agosto 2026 A | · | 0 | 0 | $0 |
| Jamie G Kates | Chief Accounting Officer | 12 Giugno 2026 M | 2.368 | 0 | 1 | $-268.450 |
| Durga Prasad Koka | EVP, Global CIO | 01 Giugno 2026 F | 6.552 | 0 | 0 | $0 |
| George Kurian | Direttore | 31 Agosto 2026 A | 4.560 | 0 | 0 | $0 |
| Neesha Hathi | Direttore | 22 Aprile 2026 A | 4.151 | 0 | 0 | $0 |
| Philip Ozuah | Direttore | 22 Aprile 2026 A | 2.583 | 0 | 0 | $0 |
| Mark B. Mcclellan | Direttore | 22 Aprile 2026 A | 6.891 | 0 | 0 | $0 |
| Kimberly A. Ross | Direttore | 22 Aprile 2026 A | 5.294 | 0 | 0 | $0 |
| Michael J Hennigan | Direttore | 22 Aprile 2026 A | 1.350 | 0 | 0 | $0 |
| Kathleen M Mazzarella | Direttore | 22 Aprile 2026 A | 6.891 | 0 | 0 | $0 |
| Donna F Zarcone | Direttore | 22 Aprile 2026 A | 27.517 | 0 | 0 | $0 |
| Eric C Wiseman | Direttore | 22 Aprile 2026 A | 23.940 | 0 | 0 | $0 |
| Eric J Foss | Direttore | 22 Aprile 2026 A | 36.696 | 0 | 0 | $0 |
| David J Brailer | · | 29 Agosto 2025 F | 17.525 | 0 | 0 | $0 |
| Elder Granger | · | 23 Aprile 2025 A | 6.109 | 0 | 0 | $0 |
| Noelle K Eder | · | 07 Marzo 2025 S | 13.406 | 0 | 0 | $0 |
| Eric P Palmer | · | 28 Febbraio 2025 A | 66.160 | 0 | 0 | $0 |
| William J Delaney III | · | 19 Agosto 2024 M | 17.539 | 0 | 0 | $0 |
| Michael W Triplett | · | 12 Agosto 2024 M | 32.833 | 0 | 0 | $0 |
| Mary T Hoeltzel | · | 14 Maggio 2024 M | 2.595 | 0 | 0 | $0 |
| Cynthia Ryan | · | 30 Agosto 2023 M | 5.937 | 0 | 0 | $0 |
| Paul A Sanford | · | 19 Luglio 2023 S | 8.679 | 0 | 0 | $0 |
| Jason D Sadler | · | 24 Febbraio 2023 A | 47.015 | 0 | 0 | $0 |
| Charles Berg | · | 08 Febbraio 2023 G | · | 0 | 0 | $0 |
| John Partridge | · | 26 Aprile 2022 A | 28.177 | 0 | 0 | $0 |
| MURABITO JOHN M | · | 01 Marzo 2022 F | 51.226 | 0 | 0 | $0 |
| HARRIS ISAIAH JR | · | 30 Novembre 2021 A | 20.015 | 0 | 0 | $0 |
| Matthew G Manders | · | 19 Novembre 2021 F | 43.488 | 0 | 0 | $0 |
| Timothy C Wentworth | · | 12 Maggio 2021 G | 29.783 | 0 | 0 | $0 |
| Kristen Lauria | · | 30 Aprile 2021 F | 2.785 | 0 | 0 | $0 |
| Steven B Miller | · | 26 Febbraio 2021 F | 28.439 | 0 | 0 | $0 |
| William L Roper | · | 26 Febbraio 2021 A | 8.583 | 0 | 0 | $0 |
| Roman Martinez IV | · | 30 Novembre 2020 A | 48.839 | 0 | 0 | $0 |
| Mark L Boxer | · | 28 Febbraio 2020 F | 49.191 | 0 | 0 | $0 |
| ZOLLARS WILLIAM D | · | 13 Settembre 2019 S | 13.500 | 0 | 0 | $0 |
| Lisa R Bacus | · | 01 Marzo 2019 F | 24.024 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 156 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| IHF · iShares Trust | 4,00% | 186.760 SH | 11 Settembre 2026 | Giornaliero |
| DUSA · Davis Fundamental ETF Trust | 3,12% | 142.104 NS | 31 Luglio 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 2,29% | 86.083 NS | 31 Luglio 2026 | N-PORT |
| SMRI · EA Series Trust | 1,79% | 41.365 NS | 31 Luglio 2026 | N-PORT |
| BMVP · Invesco Exchange-Traded Fund Trust | 1,73% | 6.426 SH | 02 Ottobre 2026 | Giornaliero |
| RPV · Invesco Exchange-Traded Fund Trust | 1,61% | 100.414 SH | 02 Ottobre 2026 | Giornaliero |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,59% | 51.721 SH | 02 Ottobre 2026 | Giornaliero |
| PWV · Invesco Exchange-Traded Fund Trust | 1,46% | 99.278 SH | 02 Ottobre 2026 | Giornaliero |
| NUDV · Nushares ETF Trust | 1,45% | 2.607 NS | 31 Luglio 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 1,40% | 505.789 SH | 02 Ottobre 2026 | Giornaliero |
| DWLD · Davis Fundamental ETF Trust | 1,36% | 29.890 NS | 31 Luglio 2026 | N-PORT |
| IYH · iShares Trust | 1,18% | 152.840 SH | 11 Settembre 2026 | Giornaliero |
| SPGP · Invesco Exchange-Traded Fund Trust | 1,17% | 89.096 SH | 02 Ottobre 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | 1,07% | 792.582 SH | 19 Agosto 2026 | Giornaliero |
| FHLC · FIDELITY COVINGTON TRUST | 1,06% | 125.422 NS | 31 Luglio 2026 | N-PORT |
| IMCV · iShares Trust | 1,00% | 41.404 SH | 11 Settembre 2026 | Giornaliero |
| FFLV · FIDELITY COVINGTON TRUST | 0,97% | 573 NS | 31 Luglio 2026 | N-PORT |
| REVS · Columbia ETF Trust I | 0,95% | 11.306 NS | 31 Luglio 2026 | N-PORT |
| IXJ · iShares Trust | 0,94% | 139.115 SH | 11 Settembre 2026 | Giornaliero |
| RILA · Spinnaker ETF Series | 0,93% | 1.412 NS | 31 Luglio 2026 | N-PORT |
| VLUE · iShares Trust | 0,90% | 308.315 SH | 11 Settembre 2026 | Giornaliero |
| FBCV · FIDELITY COVINGTON TRUST | 0,88% | 5.567 NS | 31 Luglio 2026 | N-PORT |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0,88% | 30.767.177 | 01 Ottobre 2026 | Giornaliero |
| FTA · First Trust Exchange-Traded AlphaDE… | 0,87% | 43.607 NS | 31 Luglio 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0,85% | 5.205 NS | 31 Luglio 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,80% | 24.655 SH | 19 Agosto 2026 | Giornaliero |
| EQIN · Columbia ETF Trust I | 0,77% | 8.375 NS | 31 Luglio 2026 | N-PORT |
| NULV · Nushares ETF Trust | 0,72% | 56.688 NS | 31 Luglio 2026 | N-PORT |
| CVY · Invesco Exchange-Traded Fund Trust | 0,68% | 2.953 SH | 02 Ottobre 2026 | Giornaliero |
| DFLV · Dimensional ETF Trust | 0,63% | 152.491 NS | 31 Luglio 2026 | N-PORT |
| RECS · Columbia ETF Trust I | 0,61% | 128.339 NS | 31 Luglio 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,61% | 22.064 SH | 02 Ottobre 2026 | Giornaliero |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 0,61% | 17.898.000 | 02 Ottobre 2026 | Giornaliero |
| IIGD · Invesco Exchange-Traded Self-Indexe… | 0,57% | 150.000 | 02 Ottobre 2026 | Giornaliero |
| FFLC · FIDELITY COVINGTON TRUST | 0,56% | 24.069 NS | 31 Luglio 2026 | N-PORT |
| FDLO · FIDELITY COVINGTON TRUST | 0,55% | 28.136 NS | 31 Luglio 2026 | N-PORT |
| FEUS · FlexShares Trust | 0,55% | 2.200 NS | 31 Luglio 2026 | N-PORT |
| WLDR · Two Roads Shared Trust | 0,53% | 1.744 NS | 31 Luglio 2026 | N-PORT |
| IMCB · iShares Trust | 0,50% | 29.774 SH | 11 Settembre 2026 | Giornaliero |
| QLC · FlexShares Trust | 0,48% | 17.472 NS | 31 Luglio 2026 | N-PORT |
| QIDX · Spinnaker ETF Series | 0,48% | 664 NS | 31 Luglio 2026 | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,46% | 25.557 NS | 31 Luglio 2026 | N-PORT |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,44% | 2.633 NS | 31 Luglio 2026 | N-PORT |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,43% | 560.000 | 02 Ottobre 2026 | Giornaliero |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0,43% | 19.669.000 | 02 Ottobre 2026 | Giornaliero |
| XOEF · iShares Trust | 0,42% | 331 SH | 11 Settembre 2026 | Giornaliero |
| DFUV · Dimensional ETF Trust | 0,37% | 206.037 NS | 31 Luglio 2026 | N-PORT |
| JOYT · J.P. Morgan Exchange-Traded Fund Tr… | 0,37% | 1.294 NS | 31 Luglio 2026 | N-PORT |
| ESMV · iShares Trust | 0,37% | 102 SH | 11 Settembre 2026 | Giornaliero |
| CATH · Global X Funds | 0,35% | 16.346 NS | 31 Luglio 2026 | N-PORT |
| MGV · VANGUARD WORLD FUND | 0,34% | 166.268 SH | 19 Agosto 2026 | Giornaliero |
| DGRO · iShares Trust | 0,33% | 509.486 SH | 11 Settembre 2026 | Giornaliero |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0,32% | 9.701 NS | 31 Luglio 2026 | N-PORT |
| HELO · J.P. Morgan Exchange-Traded Fund Tr… | 0,32% | 52.531 NS | 31 Luglio 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0,30% | 111.655 SH | 02 Ottobre 2026 | Giornaliero |
| VYM · VANGUARD WHITEHALL FUNDS | 0,30% | 1.042.139 SH | 19 Agosto 2026 | Giornaliero |
| EVUS · iShares Trust | 0,30% | 4.037 SH | 11 Settembre 2026 | Giornaliero |
| DFVX · Dimensional ETF Trust | 0,28% | 5.359 NS | 31 Luglio 2026 | N-PORT |
| IWX · iShares Trust | 0,27% | 37.789 SH | 11 Settembre 2026 | Giornaliero |
| VTV · VANGUARD INDEX FUNDS | 0,27% | 2.516.218 SH | 19 Agosto 2026 | Giornaliero |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,26% | 4.203 NS | 31 Luglio 2026 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,25% | 60.916 SH | 19 Agosto 2026 | Giornaliero |
| IVE · iShares Trust | 0,25% | 438.897 SH | 11 Settembre 2026 | Giornaliero |
| DFSU · Dimensional ETF Trust | 0,25% | 20.149 NS | 31 Luglio 2026 | N-PORT |
| VEGN · ETF Series Solutions | 0,24% | 1.532 NS | 31 Luglio 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,24% | 6.130 SH | 19 Agosto 2026 | Giornaliero |
| IUSV · iShares Trust | 0,24% | 231.763 SH | 11 Settembre 2026 | Giornaliero |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0,23% | 6.639.000 | 02 Ottobre 2026 | Giornaliero |
| CHRI · Global X Funds | 0,22% | 64 NS | 31 Luglio 2026 | N-PORT |
| IQSU · New York Life Investments ETF Trust | 0,22% | 2.603 NS | 31 Luglio 2026 | N-PORT |
| SUSL · iShares Trust | 0,22% | 9.336 SH | 11 Settembre 2026 | Giornaliero |
| ACVF · ETF Opportunities Trust | 0,21% | 1.165 NS | 31 Luglio 2026 | N-PORT |
| DSI · iShares Trust | 0,21% | 40.359 SH | 11 Settembre 2026 | Giornaliero |
| ILCV · iShares Trust | 0,21% | 9.900 SH | 11 Settembre 2026 | Giornaliero |
| DXUV · Dimensional ETF Trust | 0,21% | 4.094 NS | 31 Luglio 2026 | N-PORT |
| EUSA · iShares, Inc. | 0,21% | 14.065 SH | 11 Settembre 2026 | Giornaliero |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,20% | 157.624 SH | 19 Agosto 2026 | Giornaliero |
| IWD · iShares Trust | 0,20% | 580.231 SH | 11 Settembre 2026 | Giornaliero |
| RSP · Invesco Exchange-Traded Fund Trust | 0,20% | 701.739 SH | 02 Ottobre 2026 | Giornaliero |
| ACWV · iShares, Inc. | 0,19% | 23.190 SH | 11 Settembre 2026 | Giornaliero |
| ESGU · iShares Trust | 0,19% | 122.944 SH | 11 Settembre 2026 | Giornaliero |
| ROUS · Lattice Strategies Trust | 0,19% | 4.742 NS | 31 Luglio 2026 | N-PORT |
| MPLY · Strategy Shares | 0,18% | 104 NS | 31 Luglio 2026 | N-PORT |
| SIZE · iShares Trust | 0,18% | 2.691 SH | 11 Settembre 2026 | Giornaliero |
| GLBL · Pacer Funds Trust | 0,18% | 7 NS | 31 Luglio 2026 | N-PORT |
| USMV · iShares Trust | 0,17% | 144.573 SH | 11 Settembre 2026 | Giornaliero |
| EGLE · Global X Funds | 0,17% | 13 NS | 31 Luglio 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,16% | 28.112 SH | 02 Ottobre 2026 | Giornaliero |
| DFAC · Dimensional ETF Trust | 0,15% | 249.847 NS | 31 Luglio 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,14% | 63.351 NS | 31 Luglio 2026 | N-PORT |
| MGC · VANGUARD WORLD FUND | 0,14% | 52.742 SH | 19 Agosto 2026 | Giornaliero |
| TOPC · iShares Trust | 0,14% | 159 SH | 11 Settembre 2026 | Giornaliero |
| DIVB · iShares Trust | 0,13% | 9.546 SH | 11 Settembre 2026 | Giornaliero |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,13% | 8.131 SH | 02 Ottobre 2026 | Giornaliero |
| IWL · iShares Trust | 0,13% | 10.119 SH | 11 Settembre 2026 | Giornaliero |
| XVV · iShares Trust | 0,13% | 3.041 SH | 11 Settembre 2026 | Giornaliero |
| VV · VANGUARD INDEX FUNDS | 0,12% | 308.954 SH | 19 Agosto 2026 | Giornaliero |
| ESGV · VANGUARD WORLD FUND | 0,12% | 59.034 SH | 19 Agosto 2026 | Giornaliero |
| XYLD · Global X Funds | 0,12% | 13.766 NS | 31 Luglio 2026 | N-PORT |
| ACIO · ETF Series Solutions | 0,12% | 9.915 NS | 31 Luglio 2026 | N-PORT |
| ADME · ETF Series Solutions | 0,11% | 1.207 NS | 31 Luglio 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,11% | 13.352 NS | 31 Luglio 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,11% | 13.613 NS | 31 Luglio 2026 | N-PORT |
| XRMI · Global X Funds | 0,11% | 203 NS | 31 Luglio 2026 | N-PORT |
| IVV · iShares Trust | 0,11% | 3.332.808 SH | 11 Settembre 2026 | Giornaliero |
| BKLC · BNY Mellon ETF Trust | 0,11% | 21.844 NS | 31 Luglio 2026 | N-PORT |
| XYLG · Global X Funds | 0,11% | 255 NS | 31 Luglio 2026 | N-PORT |
| XTR · Global X Funds | 0,11% | 19 NS | 31 Luglio 2026 | N-PORT |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,11% | 35.099 NS | 31 Luglio 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0,11% | 6.870.735 SH | 19 Agosto 2026 | Giornaliero |
| TOV · EA Series Trust | 0,11% | 1.059 NS | 31 Luglio 2026 | N-PORT |
| XCLR · Global X Funds | 0,11% | 14 NS | 31 Luglio 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0,11% | 4.302 NS | 31 Luglio 2026 | N-PORT |
| PBP · Invesco Exchange-Traded Fund Trust | 0,11% | 1.573 SH | 02 Ottobre 2026 | Giornaliero |
| DFUS · Dimensional ETF Trust | 0,11% | 80.995 NS | 31 Luglio 2026 | N-PORT |
| ILCB · iShares Trust | 0,11% | 4.927 SH | 11 Settembre 2026 | Giornaliero |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,11% | 45.808 SH | 02 Ottobre 2026 | Giornaliero |
| IYY · iShares Trust | 0,11% | 11.380 SH | 11 Settembre 2026 | Giornaliero |
| SPUU · Direxion Shares ETF Trust | 0,11% | 998 NS | 31 Luglio 2026 | N-PORT |
| IWB · iShares Trust | 0,10% | 180.235 SH | 11 Settembre 2026 | Giornaliero |
| QDPL · Pacer Funds Trust | 0,10% | 6.372 NS | 31 Luglio 2026 | N-PORT |
| ESG · FlexShares Trust | 0,10% | 480 NS | 31 Luglio 2026 | N-PORT |
| VOXP · Advisors Series Trust | 0,10% | 21 NS | 31 Luglio 2026 | N-PORT |
| ITOT · iShares Trust | 0,10% | 343.920 SH | 11 Settembre 2026 | Giornaliero |
| IWV · iShares Trust | 0,10% | 71.744 SH | 11 Settembre 2026 | Giornaliero |
| VTI · VANGUARD INDEX FUNDS | 0,10% | 8.400.121 SH | 19 Agosto 2026 | Giornaliero |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,10% | 43.269 SH | 19 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,10% | 21.990 SH | 19 Agosto 2026 | Giornaliero |
| LGDX · Tidal Trust III | 0,10% | 497 NS | 31 Luglio 2026 | N-PORT |
| TILT · FlexShares Trust | 0,09% | 7.268 NS | 31 Luglio 2026 | N-PORT |
| HCMT · Direxion Shares ETF Trust | 0,09% | 1.842 NS | 31 Luglio 2026 | N-PORT |
| PHDG · Invesco Actively Managed Exchange-T… | 0,09% | 209 SH | 02 Ottobre 2026 | Giornaliero |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 2.691 SH | 02 Ottobre 2026 | Giornaliero |
| TOK · iShares Trust | 0,09% | 744 SH | 11 Settembre 2026 | Giornaliero |
| SPXL · Direxion Shares ETF Trust | 0,09% | 20.684 NS | 31 Luglio 2026 | N-PORT |
| URTH · iShares, Inc. | 0,08% | 23.813 SH | 11 Settembre 2026 | Giornaliero |
| LRGF · iShares Trust | 0,08% | 10.058 SH | 11 Settembre 2026 | Giornaliero |
| ACWI · iShares Trust | 0,07% | 83.068 SH | 11 Settembre 2026 | Giornaliero |
| USCL · iShares Trust | 0,07% | 6.976 SH | 11 Settembre 2026 | Giornaliero |
| NULC · Nushares ETF Trust | 0,06% | 152 NS | 31 Luglio 2026 | N-PORT |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,06% | 219.986 SH | 19 Agosto 2026 | Giornaliero |
| GLOF · iShares Trust | 0,02% | 150 SH | 11 Settembre 2026 | Giornaliero |
| PEVC · Pacer Funds Trust | 0,01% | 1 NS | 31 Luglio 2026 | N-PORT |
| GTO · Invesco Actively Managed Exchange-T… | 0,00% | 109.800 | 02 Ottobre 2026 | Giornaliero |
| GTOS · Invesco Actively Managed Exchange-T… | 0,00% | 400 | 30 Settembre 2026 | Giornaliero |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| VUSB · VANGUARD BOND INDEX FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 Luglio 2026 | Giornaliero |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30 Luglio 2026 | Giornaliero |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 30 Luglio 2026 | Giornaliero |
| VCEB · VANGUARD WORLD FUND | · | · | 30 Luglio 2026 | Giornaliero |
CI Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
Target Price a 12 Mesi
24 analisti · 2026-10-02Target medio $342.29 +26,5%
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| CI | $72.51B | 12.4 | 11.2% | 2.2% | 14.4% | · |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | · |
| DGX | $19.09B | 19.8 | 11.8% | 9.0% | 14.2% | · |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| GH | $13.34B | -30.8 | 32.9% | -42.4% | 205.7% | · |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| BTSG | $7.20B | 43.0 | 28.2% | 1.5% | 10.8% | 11.8% |
| DVA | $7.79B | 11.5 | 6.5% | 5.5% | -281.8% | · |
| HNGE | $0 | -6.0 | 50.6% | -89.9% | -299.8% | 79.7% |
| HIMS | · | 63.7 | 59.0% | 5.5% | 23.3% | 73.8% |
| CHE | · | 23.3 | 4.1% | 10.5% | 24.4% | · |
Ultime notizie Notizie recenti che menzionano questa società
Segnali di trading Segnali recenti di acquisto/vendita con prezzo di entrata e rapporto rischio/rendimento
Nessun segnale aperto al momento — nessuna scheda è compilata, e questo è onesto.
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.